-
MLYS Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Mineralys Therapeutics (MLYS)
Company Profile
Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 97.27 mm | 97.27 mm | 97.27 mm | 97.27 mm | 97.27 mm | |
Cash burn (monthly) | (no burn) | 322.17 k | 20.04 mm | 12.45 mm | 5.60 mm | |
Cash used (since last report) | n/a | 902.72 k | 56.14 mm | 34.90 mm | 15.68 mm | |
Cash remaining | n/a | 96.37 mm | 41.13 mm | 62.38 mm | 81.59 mm | |
Runway (months of cash) | n/a | 299.1 | 2.1 | 5.0 | 14.6 |
13F holders | Current |
---|---|
Total holders | 54 |
Opened positions | 19 |
Closed positions | 41 |
Increased positions | 18 |
Reduced positions | 7 |
13F shares | Current |
---|---|
Total value | 275.83 bn |
Total shares | 30.98 mm |
Total puts | 1.60 k |
Total calls | 17.00 k |
Total put/call ratio | 0.1 |
Largest owners | Shares | Value |
---|---|---|
Samsara BioCapital | 5.07 mm | $59.38 bn |
Ra Capital Management | 4.85 mm | $56.76 bn |
Samsara BioCapital | 4.52 mm | $81.39 mm |
TCG Crossover Management | 3.19 mm | $37.27 bn |
Andera Partners | 2.87 mm | $51.62 mm |
Orbimed Advisors | 2.02 mm | $23.65 bn |
BEN Franklin Resources | 1.48 mm | $17.35 bn |
Laurion Capital Management | 1.46 mm | $17.04 bn |
Caligan Partners | 745.76 k | $8.73 bn |
Octagon Capital Advisors | 600.00 k | $7.02 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
11 Dec 24 | David Malcom Rodman | Common Stock | Option exercise | Acquire M | No | No | 0.54 | 5,017 | 2.71 k | 146,008 |
11 Dec 24 | David Malcom Rodman | Stock Option Common Stock | Option exercise | Dispose M | No | No | 0.54 | 5,017 | 2.71 k | 5,018 |
11 Nov 24 | David Malcom Rodman | Common Stock | Sell | Dispose S | No | Yes | 15.0016 | 5,026 | 75.40 k | 140,991 |
11 Nov 24 | David Malcom Rodman | Common Stock | Option exercise | Acquire M | No | Yes | 1.08 | 5,026 | 5.43 k | 146,017 |
11 Nov 24 | David Malcom Rodman | Common Stock | Option exercise | Acquire M | No | No | 0.54 | 5,017 | 2.71 k | 140,991 |
11 Nov 24 | David Malcom Rodman | Stock Option Common Stock | Option exercise | Dispose M | No | No | 1.08 | 5,026 | 5.43 k | 134,926 |
11 Nov 24 | David Malcom Rodman | Stock Option Common Stock | Option exercise | Dispose M | No | No | 0.54 | 5,017 | 2.71 k | 10,035 |
6 Nov 24 | David Malcom Rodman | Common Stock | Sell | Dispose S | No | Yes | 15.0328 | 25,482 | 383.07 k | 135,974 |
6 Nov 24 | David Malcom Rodman | Common Stock | Option exercise | Acquire M | No | Yes | 1.08 | 25,482 | 27.52 k | 161,456 |
6 Nov 24 | David Malcom Rodman | Stock Option Common Stock | Option exercise | Dispose M | No | No | 1.08 | 25,482 | 27.52 k | 139,952 |